Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Intiva Health Announces New Partnership with Hosts of Bad Crypto Podcast


AUSTIN, Texas, April 20, 2018 /PRNewswire/ -- Intiva Health, a decentralized credentialing and verification platform for medical professionals, announced a new strategic partnership with the founders and co-hosts of Bad Crypto Podcast, widely recognized as influential thought leaders in the blockchain and cryptocurrency communities.

Intiva Health (PRNewsfoto/Intiva Health)

Joel Comm and Travis Wright produce one of the leading podcasts in the industry, and will help Intiva promote the sale of the Intiva Token.*

"We're very excited to team up with top thought leaders in blockchain to help us spread the word about our token sale," said John Hartigan, Intiva Health's executive vice president. "We've been big fans of Bad Crypto Podcast for a while and are stoked to join forces with Joel and Travis".

Intiva's token is the first to directly serve the medical professional market. Each time an action is taken on the Intiva Health platform, medical professionals will receive a token, which they can then use to purchase goods and services on the platform, such as continuing medical education (CME) courses or malpractice insurance.

Interested investors can find more information about the Intiva Token by visiting: https://token.intivahealth.com. The private sale is currently underway. The presale starts April 30th and is open to US and international investors.

Joel Comm is a New York Times bestselling author, blockchain enthusiast, professional keynote speaker, social media marketing strategist, live video expert, technologist, brand influencer, and futurist. Joel has over two decades of experience harnessing the power of digital marketing and social media. He is a sought-after public speaker who leaves his audiences inspired, entertained, and armed with strategic tools to create highly effective media campaigns.

Travis Wright is a top marketing technologist, author, keynote speaker, blockchain advisor, tech journalist, and podcast host. He is the former global digital and social strategist at Symantec for the Norton brand. Wright is the co-founder and CMO of CCP.Digital, a Kansas City and San Francisco-based digital media and content agency. He is the author of Wiley & Sons, "Digital Sense, The Common Sense Approach to Social Business Strategy, Marketing Technologies, Customer Experience and Emerging Technologies," published in January 2017. In addition to  co-hosting the Bad Crypto Podcast, he also co-hosts Venture Beat's podcast, VB Engage.

About Intiva Health
Intiva Health's mission is to aid healthcare professionals through every step of their career. Their platform completely redefines the medical credentialing and verification process to save the industry billions. Intiva sets the new standard for medical credential verification, improving the quality of healthcare for all. Intiva Health is headquartered in Austin, Texas.www.intivahealth.com | @Intivahealth.

*Individuals outside of the U.S. may purchase the Intiva Token. Intiva Token, Inc is also undergoing Share Offering for U.S. Accredited Investors, who receive the token as a shareholder benefit.

 

SOURCE Intiva Health


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: